The Clinical Trials Centre is made up of clinical staff at St Mary’s Hospital and laboratory, operational and management staff at Imperial College London. The clinical team have close links to the Jefferiss Wing at St Mary’s Hospital, a leading UK provider of HIV and sexual health care.
The centre has been researching clinical care for HIV and AIDS for over 30 years. The unit opened in June 1991, with financial support from the Elton John AIDS Foundation and the Jefferiss Trust. Over time, the unit has expanded its remit to undertake research in sexual health, sexual function and infectious diseases. In more recent years, the unit has led several Covid-19 vaccine trials.
The research conducted at the Clinical Trials Centre has been pivotal to improving knowledge around how to care best for people with HIV, with many of these research findings integrated into national guidelines (British HIV Association guidelines).
The centre supports both commercial and non-commercial/academic studies.
Patient and public involvement (PPI) and engagement:
The team at the Clinical Trials Centre are keen to work with the local community to help shape the direction of future research. Patient and Public Involvement and Engagement (PPIE) activities including sharing ideas about future research questions, reviewing and re-shaping study documents before ethics submissions (e.g. study protocols and patient information sheets) and helping share research results with the wider community.
Latest news
-
Read the full story
Focal therapy for prostate cancer is cost-effective and may improve patient outcomes
Minimally invasive therapies for prostate cancer which remove the cancer while leaving the rest of the prostate intact are associated with lower costs for the NHS and benefits for patients. These are the findings of a new study, published recently…
-
Read the full story
Antimicrobial resistance: securing the future
The discovery of penicillin in 1928 at St Mary’s Hospital marked the beginning of the antibiotic revolution and earned Sir Alexander Fleming a Nobel Prize. Almost a century on, these medicines have saved countless lives globally by killing bacteria…
-
Read the full story
UK Government backs Fleming Centre to fight threat of drug resistant infections
The UK Government has committed £5million in seed funding to support a joint initiative to fight antimicrobial resistance.